Abstract:Sudden cardiac death (SCD), one of the most common causes of human death, has become a major health and social problem. The postmortem diagnosis and prevention of SCD remain primary challenges in the medical community due to the lack of reliable diagnostic biomarkers. Time-of-flight secondary ion mass spectrometry (ToF-SIMS) is a sensitive surface analysis technique for analyzing tissue slices with high spatial resolution. Here, ToF-SIMS followed by principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA) were employed to study the SCD mouse myocardium samples and obtain high-resolution chemical mappings and mass spectra. Distinction between normal control (NC) and acute β-adrenergic receptor (β-AR) activation-induced SCD groups was primarily due to the changes of diacylglycerols (DAG), phosphatidylcholine (PC), lysophosphatidylcholine (LysoPC) and sphingomyelin (SM) in positive mode. Meanwhile, chemical mapping of the myocardium showed different lipid distributions in the SCD mouse myocardium. The metabolite alterations in mouse models were further verified by analyzing the heart tissue sections of a 28-year-old woman that died from isoprenaline injection. This pilot study demonstrated the significance of ToF-SIMS in characterizing the lipid variations in SCD heart tissues and might contribute to the postmortem diagnosis of SCD, the discovery of molecule candidates to discriminate the progression of SCD and the understanding of the potential postmortem diagnostic significance of SCD.

Correction: Investigation of Heart Lipid Changes in Acute Β-Ar Activation-Induced Sudden Cardiac Death by Time-of-flight Secondary Ion Mass Spectrometry.

Investigation of heart lipid changes in acute beta-AR activation-induced sudden cardiac death by time-of-flight secondary ion mass spectrometry (vol 145, pg 5889, 2020)

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Correction: Corrigendum: Quantitative real-time imaging of glutathione

Investigation of Heart Lipid Changes in Acute Β-Ar Activation-Induced Sudden Cardiac Death by Time-of-flight Secondary Ion Mass Spectrometry

Correction: Open-flow microperfusion combined with mass spectrometry for in vivo liver lipidomic analysis

Corrigendum to “the Induction of Reactive Oxygen Species and Loss of Mitochondrial Omi/HtrA2 is Associated with S-nitrosoglutathione-induced Apoptosis in Human Endothelial Cells” [toxicology and Applied Pharmacology 244 (2010) 374–384]

Corrigendum: Single-cell RNA Sequencing of Peripheral Blood Mononuclear Cells from Acute Myocardial Infarction.

[Corrigendum] Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction

Correction: Investigation of plasma metabolomics and neurotransmitter dysfunction in the process of Alzheimer’s disease rat induced by amyloid beta 25-35

Correction: A Proteomic Study of Shengmai Injection's Mechanism on Preventing Cardiac Ischemia-Reperfusion Injury Via Energy Metabolism Modulation

Correction: Polydopamine-capped AgNPs as a novel matrix overcoming the ion suppression of phosphatidylcholine for MALDI MS comprehensive imaging of glycerophospholipids and sphingolipids in impact-induced injured brain

Corrigendum to “FUNDC1 Insufficiency Sensitizes High Fat Diet Intake-Induced Cardiac Remodeling and Contractile Anomaly Through ACSL4-mediated Ferroptosis” [metabolism 122 (september 2021) 154840]

[Corrigendum] Antioxidant effects of hydroxysafflor yellow A and acetyl-11-keto-β-boswellic acid in combination on isoproterenol-induced myocardial injury in rats

Corrigendum: A comparative study of two in vivo PET verification methods in clinical cases

Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

Corrigendum: Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics

Corrigendum to "Salvia miltiorrhiza and the Volatile of Dalbergia odorifera Attenuate Chronic Myocardial Ischemia Injury in a Pig Model: A Metabonomic Approach for the Mechanism Study"

Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction

Author Correction: Pharmacokinetics, mass balance, and metabolism of [ 14 C]vicagrel, a novel irreversible P2Y 12 inhibitor in humans